Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | +3.61% | +2.79% | -14.00% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 80
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Andreas Muehler
CTO | Chief Tech/Sci/R&D Officer | 60 | 16-07-31 |
Jessica Breu
IRC | Investor Relations Contact | - | - |
Patrick Walsh
PRN | Corporate Officer/Principal | 41 | 21-10-13 |
Inderpal Singh
LAW | General Counsel | 58 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Duane Nash
CHM | Chairman | 53 | 18-12-31 |
Richard Rudick
BRD | Director/Board Member | 73 | 23-04-25 |
Monika Tornsen
BRD | Director/Board Member | 45 | 22-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,079,016 | 83,120,924 ( 92.28 %) | 0 | 92.28 % |
Company contact information
Immunic, Inc.
1200 Avenue of the Americas Suite 200
10036, New York
+
http://www.immunic-therapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.00% | 116M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.49% | 21.6B | |
-12.38% | 22.31B | |
-6.87% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- IMUX Stock
- Company Immunic, Inc.